Plasma enterolignan concentrations and colorectal cancer risk in a nested case-control study

American Journal of Epidemiology

Volumn 167, Issue 6, 2008, Pages 734-742

  Kuijsten, Anneleen ^a,b   Hollman, Peter C H ^b   Boshuizen, Hendriek C ^a   Buijsman, Michel N C P ^b   Van't Veer, Pieter ^b   Kok, Frans J ^b   Arts, Ilja C W ^b   Bueno De Mesquita, H Bas ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

Biological markers; Colorectal neoplasms; Lignans; Prospective studies

Indexed keywords

BIPHENOL DERIVATIVE; ENTERODIOL; ENTEROLACTONE; ENTEROLIGNAN; LIGNAN; PHENOL; UNCLASSIFIED DRUG;

AGE; BIOMARKER; BLOOD; BODY MASS; CANCER; COHORT ANALYSIS; EXCRETION; HEALTH RISK; PHENOLIC COMPOUND; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ADULT; ARTICLE; BODY MASS; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ADULT; BIPHENYL COMPOUNDS; BODY MASS INDEX; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIGNANS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 41149099498     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm349     Document Type: Article

References (55)

1. Marques-Vidal P, Ravasco P, Ermelinda Camilo M. Foodstuffs and colorectal cancer risk: a review. Clin Nutr 2006;25:14-36.
2. Norat T, Riboli E. Meat consumption and colorectal cancer: a review of epidemiologic evidence. Nutr Rev 2001;59:37-47.
3. Milder IEJ, Arts ICW, Putte B, et al. Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 2005;93:393-402.
4. Axelson M, Sjoevall J, Gustafsson BE, et al. Origin of lignans in mammals and identification of a precursor from plants. Nature 1982;298:659-60.
5. Borriello SP, Setchell KD, Axelson M, et al. Production and metabolism of lignans by the human faecal flora. J Appl Bacteriol 1985;58:37-43.
6. Heinonen S, Nurmi T, Liukkonen K, et al. In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 2001;49:3178-86.
7. Sung MK, Lautens M, Thompson LU. Mammalian lignans inhibit the growth of estrogen-independent human colon tumor cells. Anticancer Res 1998;18:1405-8.
8. Qu H, Madl RL, Takemoto DJ, et al. Lignans are involved in the antitumor activity of wheat bran in colon cancer SW480 cells. J Nutr 2005;135:598-602.
9. Kitts DD, Yuan YV, Wijewickreme AN, et al. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol Cell Biochem 1999;202:91-100.
10. Prasad K. Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone. Int J Angiol 2000;9:220-5.
11. Adlercreutz H, Mousavi Y, Clark J, et al. Dietary phytoestrogens and cancer - in vitro and in vivo studies. J Steroid Biochem Mol Biol 1992;41:331-7.
12. Adlercreutz H, Bannwart C, Wahala K, et al. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993;44:147-53.
13. Webb AL, McCullough ML. Dietary lignans: potential role in cancer prevention. Nutr Cancer 2005;51:117-31.
14. Davies MJ, Bowey EA, Adlercreutz H, et al. Effects of soy or rye supplementation of high-fat diets on colon tumour development in azoxymethane-treated rats. Carcinogenesis 1999;20:927-31.
15. Jenab M, Thompson LU. The influence of flaxseed and lignans on colon carcinogenesis and beta-glucuronidase activity. Carcinogenesis 1996;17:1343-8.
16. Oikarinen S, Heinonen SM, Nurmi T, et al. No effect on adenoma formation in Min mice after moderate amount of flax-seed. Eur J Nutr 2005;44:273-80.
17. van Kranen HJ, Mortensen A, Sorensen IK, et al. Lignan precursors from flaxseed or rye bran do not protect against the development of intestinal neoplasia in ApcMin mice. Nutr Cancer 2003;45:203-10.
18. Pajari AM, Smeds AI, Oikarinen SI, et al. The plant lignans matairesinol and secoisolariciresinol administered to Min mice do not protect against intestinal tumor formation. Cancer Lett 2005;233:309-14.
19. Kuijsten A, Arts IC, Hollman PC, et al. Plasma enterolignans are associated with lower colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2006;15:1132-6.
20. Midgley R, Kerr D. Colorectal cancer. Lancet 1999;353:391-9.
21. Wei EK, Giovannucci E, Wu K, et al. Comparison of risk factors for colon and rectal cancer. Int J Cancer 2004;108:433-42.
22. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002;101:403-8.
23. Brink M, de Goeij AF, Weijenberg MP, et al. K-ras oncogene mutations in sporadic colorectal cancer in the Netherlands Cohort Study. Carcinogenesis 2003;24:703-10.
24. Luchtenborg M, Weijenberg MP, Roemen GM, et al. APC mutations in sporadic colorectal carcinomas from the Netherlands Cohort Study. Carcinogenesis 2004;25:1219-26.
25. DeCosse JJ, Ngoi SS, Jacobson JS, et al. Gender and colorectal cancer. Eur J Cancer Prev 1993;2:105-15.
26. Hebert-Croteau N. A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev 1998;7:653-9.
27. Verschuren WM, Boerma GJ, Kromhout D. Total and HDL-cholesterol in the Netherlands: 1987-1992. Levels and changes over time in relation to age, gender and educational level. Int J Epidemiol 1994;23:948-56.
28. Bloemberg BPM, Kromhout D, Jansen A, et al. Reproducibility and validity of a short self-administered semi-quantitative food frequency questionnaire. (Doctoral thesis). Leiden, the Netherlands: Leiden University, 1993:45-65.
29. Kuijsten A, Buijsman MNCP, Arts ICW, et al. A validated method for the quantification of enterodiol and enterolactone in plasma using isotope dilution liquid chromatography with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2005;822:178-84.
30. Dai Q, Franke AA, Jin F, et al. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev 2002;11:815-21.
31. Ingram D, Sanders K, Kolybaba M, et al. Case-control study of phyto-oestrogens and breast cancer. Lancet 1997;350:990-4.
32. Pietinen P, Stumpf K, Mannisto S, et al. Serum enterolactone and risk of breast cancer: a case-control study in Eastern Finland. Cancer Epidemiol Biomarkers Prev 2001;10:339-44.
33. Boccardo F, Lunardi G, Guglielmini P, et al. Serum enterolactone levels and the risk of breast cancer in women with palpable cysts. Eur J Cancer 2004;40:84-9.
34. Olsen A, Knudsen KEB, Thomsen BL, et al. Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidemiol Biomarkers Prev 2004;13:2084-9.
35. Grace PB, Taylor JI, Low YL, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European Prospective Investigation of Cancer and Nutrition-Norfolk. Cancer Epidemiol Biomarkers Prev 2004;13:698-708.
36. Kilkkinen A, Virtamo J, Vartiainen E, et al. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int J Cancer 2004;108:277-80.
37. Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, et al. Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer 2004;91:99-105.
38. Hulten K, Winkvist A, Lenner P, et al. An incident case-referent study on plasma enterolactone and breast cancer risk. Eur J Nutr 2002;41:168-76.
39. den Tonkelaar I, Keinan-Boker L, van 't Veer P, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:223-8.
40. Stattin P, Bylund A, Biessy C, et al. Prospective study of plasma enterolactone and prostate cancer risk (Sweden). Cancer Causes Control 2004;15:1095-102.
41. Stattin P, Adlercreutz H, Tenkanen L, et al. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study. Int J Cancer 2002;99:124-9.
42. Kilkkinen A, Virtamo J, Virtanen MJ, et al. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study. Cancer Epidemiol Biomarkers Prev 2003;12:1209-12.
43. Hernandez BY, McDuffie K, Franke AA, et al. Plasma and dietary phytoestrogens and risk of premalignant lesions of the cervix. Nutr Cancer 2004;49:109-24.
44. Jacobs ET, Lanza E, Alberts DS, et al. Fiber, sex, and colorectal adenoma: results of a pooled analysis. Am J Clin Nutr 2006;83:343-9.
45. Milder IEJ, Kuijsten A, Arts ICW, et al. Relation between plasma enterodiol and enterolactone and dietary intake of lignans in a Dutch endoscopy-based population. J Nutr 2007;137:1266-71.
46. Mueller SO, Simon S, Chae K, et al. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERα) and ERβ in human cells. Toxicol Sci 2004;80:14-25.
47. Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, et al. Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 2006;54:1611-20.
48. Pischon T, Lahmann PH, Boeing H, et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920-31.
49. Sandler RS, Jordan MC, Shelton BJ. Demographic and dietary determinants of constipation in the US population. Am J Public Health 1990;80:185-9.
50. Harari D, Gurwitz JH, Avorn J, et al. Bowel habit in relation to age and gender. Findings from the National Health Interview Survey and clinical implications. Arch Intern Med 1996;156:315-20.
51. Kilkkinen A, Stumpf K, Pietinen P, et al. Determinants of serum enterolactone concentration. Am J Clin Nutr 2001;73:1094-100.
52. Sonnenberg A, Muller AD. Constipation and cathartics as risk factors of colorectal cancer: a meta-analysis. Pharmacology 1993;47(suppl 1):224-33.
53. Watanabe T, Nakaya N, Kurashima K, et al. Constipation, laxative use and risk of colorectal cancer: The Miyagi Cohort Study. Eur J Cancer 2004;40:2109-15.
54. Kilkkinen A, Pietinen P, Klaukka T, et al. Use of oral antimicrobials decreases serum enterolactone concentration. Am J Epidemiol 2002;155:472-7.
55. Lechner D, Kallay E, Cross HS. Phytoestrogens and colorectal cancer prevention. Vitam Horm 2005;70:169-98.